SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Alexandre de Matos Soeiro, Michel Haddad, Maria Carolina Feres de Almeida, Aline D. Ruppert, Carlos V. Serrano Jr., Artrite reumatoide e doença cardiovascular: o que sabemos e o que podemos fazer pelo paciente na atualidade?, Revista Portuguesa de Cardiologia, 2012, 31, 3, 225

    CrossRef

  2. 2
    Theodoros Dimitroulas, George Giannakoulas, Haralambos Karvounis, Alexandros Garyfallos, Lukas Settas, George Kitas, B-type natriuretic peptide in rheumatic diseases: A cardiac biomarker or a sophisticated acute phase reactant?, Autoimmunity Reviews, 2012,

    CrossRef

  3. 3
    Benjamin M. Sherman, Kenneth L. Haspel, Inflammatory Diseases and the Heart, International Anesthesiology Clinics, 2012, 50, 2, 173

    CrossRef

  4. 4
    Jon T Giles, Justyna Fert-Bober, Jin Park, Clifton O Bingham, Felipe Andrade, Karen Fox-Talbot, Dimitrios Pappas, Antony Rosen, Jennifer van Eyk, Joan M Bathon, Marc K Halushka, Myocardial citrullination in rheumatoid arthritis: a correlative histopathologic study, Arthritis Research & Therapy, 2012, 14, 1, R39

    CrossRef

  5. 5
    A. Kirstin Bacani, Sherine E. Gabriel, Cynthia S. Crowson, John A. Heit, Eric L. Matteson, Noncardiac vascular disease in rheumatoid arthritis: Increase in venous thromboembolic events?, Arthritis & Rheumatism, 2012, 64, 1
  6. 6
    Alexandre de Matos Soeiro, Michel Haddad, Maria Carolina Feres de Almeida, Aline D. Ruppert, Carlos V. Serrano, Rheumatoid arthritis and cardiovascular disease: What is known about this relationship and what can currently be done for affected patients?, Revista Portuguesa de Cardiologia (English Edition), 2012, 31, 3, 225

    CrossRef

  7. 7
    Abo Malek ABDUL MUIZZ, Mohamed Said MOHD SHAHRIR, Shaharir SAZLIYANA, Masakun OTEH, Azhar Shah SHAMSUL, Heselynn HUSSEIN, A cross-sectional study of diastolic dysfunction in rheumatoid arthritis and its association with disease activity, International Journal of Rheumatic Diseases, 2011, 14, 1
  8. 8
    John M. Davis, Keith L. Knutson, Michael A. Strausbauch, Cynthia S. Crowson, Terry M. Therneau, Peter J. Wettstein, Veronique L. Roger, Eric L. Matteson, Sherine E. Gabriel, A signature of aberrant immune responsiveness identifies myocardial dysfunction in rheumatoid arthritis, Arthritis & Rheumatism, 2011, 63, 6
  9. 9
    Carmen Gómez-Vaquero, Montserrat Robustillo, Javier Narváez, Jesús Rodríguez-Moreno, Carlos González-Juanatey, Javier Llorca, Joan Miquel Nolla, Miguel Angel González-Gay, Assessment of cardiovascular risk in rheumatoid arthritis: impact of the new EULAR recommendations on the score cardiovascular risk index, Clinical Rheumatology, 2011, 31, 1, 35

    CrossRef

  10. 10
    Henry R. Kramer, Jon T. Giles, Cardiovascular disease risk in rheumatoid arthritis: Progress, debate, and opportunity, Arthritis Care & Research, 2011, 63, 4
  11. 11
    L. Kozera, J. Andrews, A. W. Morgan, Cardiovascular risk and rheumatoid arthritis--the next step: differentiating true soluble biomarkers of cardiovascular risk from surrogate measures of inflammation, Rheumatology, 2011, 50, 11, 1944

    CrossRef

  12. 12
    Fabio Cacciapaglia, Luca Navarini, Pierantonio Menna, Emanuela Salvatorelli, Giorgio Minotti, Antonella Afeltra, Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues, Autoimmunity Reviews, 2011, 10, 10, 631

    CrossRef

  13. 13
    Nicola J. Gullick, David L. Scott, Co-morbidities in established rheumatoid arthritis, Best Practice & Research Clinical Rheumatology, 2011, 25, 4, 469

    CrossRef

  14. 14
    Arun Raghav Mahankali Sridhar, Sravanthi Parasa, Udayakumar Navaneethan, Michael D. Crowell, Kevin Olden, Comprehensive study of cardiovascular morbidity in hospitalized inflammatory bowel disease patients, Journal of Crohn's and Colitis, 2011, 5, 4, 287

    CrossRef

  15. 15
    Ehab S El Desoky, Drug Therapy of Heart Failure: An Immunologic View, American Journal of Therapeutics, 2011, 18, 5, 416

    CrossRef

  16. 16
    Deborah P. M. Symmons, Sherine E. Gabriel, Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE, Nature Reviews Rheumatology, 2011, 7, 7, 399

    CrossRef

  17. 17
    Hasan Kadi, Ahmet Inanir, Abdulkadir Habiboglu, Koksal Ceyhan, Fatih Koc, Atac Çelik, Orhan Onalan, Sule Arslan, Frequency of fragmented QRS on ECG is increased in patients with rheumatoid arthritis without cardiovascular disease: a pilot study, Modern Rheumatology, 2011,

    CrossRef

  18. 18
    Jean-Frédéric Boyer, Pierre Antoine Gourraud, Alain Cantagrel, Jean Luc Davignon, Arnaud Constantin, Méta-analyse des facteurs de risque traditionnels cardiovasculaires dans la polyarthrite rhumatoïde, Revue du Rhumatisme, 2011, 78, 3, 245

    CrossRef

  19. You have free access to this content19
    R. Samanta, K. Shoukrey, R. Griffiths, Rheumatoid arthritis and anaesthesia, Anaesthesia, 2011, 66, 12
  20. 20
    Thao Pham, Hervé Bachelez, Jean-Marie Berthelot, Jacques Blacher, Yoram Bouhnik, Pascal Claudepierre, Arnaud Constantin, Bruno Fautrel, Philippe Gaudin, Vincent Goëb, Laure Gossec, Philippe Goupille, Séverine Guillaume-Czitrom, Eric Hachulla, Isabelle Huet, Denis Jullien, Odile Launay, Marc Lemann, Jean-Francis Maillefert, Jean-Pierre Marolleau, Valérie Martinez, Charles Masson, Jacques Morel, Luc Mouthon, Stanislas Pol, Xavier Puéchal, Pascal Richette, Alain Saraux, Thierry Schaeverbeke, Martin Soubrier, Anne Sudre, Tu-Anh Tran, Manuelle Viguier, Olivier Vittecoq, Daniel Wendling, Xavier Mariette, Jean Sibilia, TNF alpha antagonist therapy and safety monitoring, Joint Bone Spine, 2011, 78, 15

    CrossRef

  21. 21
    Jean-Frédéric Boyer, Pierre-Antoine Gourraud, Alain Cantagrel, Jean-Luc Davignon, Arnaud Constantin, Traditional cardiovascular risk factors in rheumatoid arthritis: A meta-analysis, Joint Bone Spine, 2011, 78, 2, 179

    CrossRef

  22. 22
    Cynthia S. Crowson, Elena Myasoedova, John M. Davis, Veronique L. Roger, Barry L. Karon, Daniel Borgeson, Richard J. Rodeheffer, Terry M. Therneau, Sherine E. Gabriel, Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease, Arthritis Care & Research, 2011, 63, 5
  23. 23
    Suzanne M.M. Verstappen, Deborah P.M. Symmons, What is the outcome of RA in 2011 and can we predict it?, Best Practice & Research Clinical Rheumatology, 2011, 25, 4, 485

    CrossRef

  24. 24
    R. Michael Benitez, Gautam Ramani, Patricia A. Uber, Rheumatology, 2011,

    CrossRef

  25. 25
    Virginia Villaverde García, Alejandro Balsa Criado, ¿El control precoz de la artritis reumatoide augura un mejor pronóstico a largo plazo?, Reumatología Clínica, 2010, 6, 2, 106

    CrossRef

  26. 26
    Vincent E. Friedewald, Peter Ganz, Joel M. Kremer, Philip J. Mease, James R. O'Dell, Thomas A. Pearson, C. Venkata S. Ram, Paul M. Ridker, Jane E. Salmon, William C. Roberts, AJC Editor's Consensus: Rheumatoid Arthritis and Atherosclerotic Cardiovascular Disease, The American Journal of Cardiology, 2010, 106, 3, 442

    CrossRef

  27. 27
    Mariana J. Kaplan, Cardiovascular Complications of Rheumatoid Arthritis: Assessment, Prevention, and Treatment, Rheumatic Disease Clinics of North America, 2010, 36, 2, 405

    CrossRef

  28. 28
    Sonali P. Desai, James L. Januzzi, Ashvin N. Pande, Eugene V. Pomerantsev, Frederic S. Resnic, Anne Fossel, Lori B. Chibnik, Daniel H. Solomon, Comparison of Symptoms, Treatment, and Outcomes of Coronary Artery Disease among Rheumatoid Arthritis and Matched Subjects Undergoing Percutaneous Coronary Intervention, Seminars in Arthritis and Rheumatism, 2010, 40, 3, 215

    CrossRef

  29. 29
    Virginia Villaverde García, Alejandro Balsa Criado, Does early treatment of Rheumatoid Arthritis lead to a better long-term prognosis?, Reumatología Clínica (English Edition), 2010, 6, 2, 106

    CrossRef

  30. 30
    Jon T. Giles, Ashkan A. Malayeri, Veronica Fernandes, Wendy Post, Roger S. Blumenthal, David Bluemke, Jens Vogel-Claussen, Moyses Szklo, Michelle Petri, Allan C. Gelber, Lyndia Brumback, João Lima, Joan M. Bathon, Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging, Arthritis & Rheumatism, 2010, 62, 4
  31. 31
    MC Kapetanovic, E Lindqvist, M Simonsson, P Geborek, T Saxne, K Eberhardt, Prevalence and predictive factors of comorbidity in rheumatoid arthritis patients monitored prospectively from disease onset up to 20 years: lack of association between inflammation and cardiovascular disease, Scandinavian Journal of Rheumatology, 2010, 39, 5, 353

    CrossRef

  32. 32
    Cynthia S. Crowson, Rheumatoid arthritis and heart disease: the chicken and the egg?, Journal of Internal Medicine, 2010, 268, 6
  33. 33
    H. M. Kremers, E. Myasoedova, C. S. Crowson, G. Savova, S. E. Gabriel, E. L. Matteson, The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases, Rheumatology, 2010, 50, 1, 6

    CrossRef

  34. 34
    Miguel A. González-Gay, Carlos González-Juanatey, Cardiovascular disease in rheumatoid arthritis. Importance and clinical management, Reumatología Clínica (English Edition), 2009, 5, 3, 95

    CrossRef

  35. 35
    Miguel A. González-Gay, Carlos González-Juanatey, Enfermedad cardiovascular en artritis reumatoide. Importancia y tratamiento clínico, Reumatología Clínica, 2009, 5, 3, 95

    CrossRef

  36. 36
    Rebecca L. Rudominer, Mary J. Roman, Richard B. Devereux, Stephen A. Paget, Joseph E. Schwartz, Michael D. Lockshin, Mary K. Crow, Lisa Sammaritano, Daniel M. Levine, Jane E. Salmon, Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction, Arthritis & Rheumatism, 2009, 60, 1
  37. 37
    Gayle E. McKellar, David W. McCarey, Naveed Sattar, Iain B. McInnes, Role for TNF in atherosclerosis? Lessons from autoimmune disease, Nature Reviews Cardiology, 2009, 6, 6, 410

    CrossRef

  38. 38
    S. L. Westlake, A. N. Colebatch, J. Baird, P. Kiely, M. Quinn, E. Choy, A. J. K. Ostor, C. J. Edwards, The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review, Rheumatology, 2009, 49, 2, 295

    CrossRef

  39. 39
    Dimitrios A. Pappas, Joan M. Bathon, Rheumatoid Arthritis, 2009,

    CrossRef

  40. 40
    Richard M. Keating, Pharmacology and Therapeutics, 2009,

    CrossRef

  41. 41
    Dimitrios A. Pappas, Janis M. Taube, Joan M. Bathon, Jon T. Giles, A 73-year-old woman with rheumatoid arthritis and shortness of breath, Arthritis Care & Research, 2008, 59, 6
  42. 42
    Joseph Solus, Cecilia P. Chung, Annette Oeser, Ingrid Avalos, Tebeb Gebretsadik, Ayumi Shintani, Paolo Raggi, Tuulikki Sokka, Theodore Pincus, C. Michael Stein, Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis, Arthritis & Rheumatism, 2008, 58, 9
  43. 43
    Maria I Danila, Nivedita M Patkar, Jeffrey R Curtis, Kenneth G Saag, Gim Gee Teng, Biologics and heart failure in rheumatoid arthritis: are we any wiser?, Current Opinion in Rheumatology, 2008, 20, 3, 327

    CrossRef

  44. 44
    Joachim Listing, Anja Strangfeld, Jörn Kekow, Matthias Schneider, Andreas Kapelle, Siegfried Wassenberg, Angela Zink, Does tumor necrosis factor α inhibition promote or prevent heart failure in patients with rheumatoid arthritis?, Arthritis & Rheumatism, 2008, 58, 3
  45. 45
    Hilal Maradit Kremers, Cynthia S. Crowson, Terry M. Therneau, Veronique L. Roger, Sherine E. Gabriel, High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: A population-based cohort study, Arthritis & Rheumatism, 2008, 58, 8
  46. 46
    Saurabh S. Dhawan, Arshed A. Quyyumi, Rheumatoid arthritis and cardiovascular disease, Current Atherosclerosis Reports, 2008, 10, 2, 128

    CrossRef

  47. 47
    C. Salvarani, C. D. Bella, L. Cimino, P. Macchioni, D. Formisano, G. Bajocchi, N. Pipitone, M. G. Catanoso, G. Restuccia, A. Ghinoi, L. Boiardi, Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis, Rheumatology, 2008, 48, 3, 250

    CrossRef

  48. 48
    Shinichi Kawai, Kortaro Tanaka, Iwao Ohno, Kazunori Utsunomiya, Yoshihiko Seino, Safety of long-term tacrolimus therapy for rheumatoid arthritis: an open-label, uncontrolled study in non-elderly patients, Modern Rheumatology, 2008, 18, 4, 345

    CrossRef

  49. 49
    John M. Davis, Véronique L. Roger, Cynthia S. Crowson, Hilal Maradit Kremers, Terry M. Therneau, Sherine E. Gabriel, The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population, Arthritis & Rheumatism, 2008, 58, 9
  50. 50
    S. Mathieu, H. Joly, G. Baron, A. Tournadre, J.-J. Dubost, J.-M. Ristori, J.-R. Lusson, M. Soubrier, Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease, Rheumatology, 2008, 47, 8, 1203

    CrossRef

  51. 51
    Soko Setoguchi, Sebastian Schneeweiss, Jerry Avorn, Jeffrey N. Katz, Michael E. Weinblatt, Raisa Levin, Daniel H. Solomon, Tumor necrosis factor-α antagonist use and heart failure in elderly patients with rheumatoid arthritis, American Heart Journal, 2008, 156, 2, 336

    CrossRef

  52. 52
    K. Z. Gong, G. Song, J. P. Spiers, E. J. Kelso, Z. G. Zhang, Activation of immune and inflammatory systems in chronic heart failure: novel therapeutic approaches, International Journal of Clinical Practice, 2007, 61, 4
  53. 53
    Kaleb Michaud, Frederick Wolfe, Comorbidities in rheumatoid arthritis, Best Practice & Research Clinical Rheumatology, 2007, 21, 5, 885

    CrossRef

  54. 54
    M. Wislowska, B. Jaszczyk, M. Kochmański, S. Sypuła, M. Sztechman, Diastolic heart function in RA patients, Rheumatology International, 2007, 28, 6, 513

    CrossRef

  55. 55
    Sherine E Gabriel, Do antirheumatic drugs increase the risk of acute myocardial infarction?, Nature Clinical Practice Rheumatology, 2007, 3, 1, 12

    CrossRef

  56. 56
    John M. Davis, Hilal Maradit Kremers, Cynthia S. Crowson, Paulo J. Nicola, Karla V. Ballman, Terry M. Therneau, Véronique L. Roger, Sherine E. Gabriel, Glucocorticoids and cardiovascular events in rheumatoid arthritis: A population-based cohort study, Arthritis & Rheumatism, 2007, 56, 3
  57. 57
    Todd A. Lee, A. Simon Pickard, Brian Bartle, Kevin B. Weiss, Osteoarthritis: A Comorbid Marker for Longer Life?, Annals of Epidemiology, 2007, 17, 5, 380

    CrossRef

  58. 58
    Cynthia S Crowson, Terry M Therneau, Eric L Matteson, Sherine E Gabriel, Primer: demystifying risk—understanding and communicating medical risks, Nature Clinical Practice Rheumatology, 2007, 3, 3, 181

    CrossRef

  59. 59
    Shaker A Mousa, Olga Goncharuk, Danny Miller, Recent advances of TNF-α antagonists in rheumatoid arthritis and chronic heart failure, Expert Opinion on Biological Therapy, 2007, 7, 5, 617

    CrossRef

  60. 60
    Kosmas I. Paraskevas, Statin treatment for rheumatoid arthritis: a promising novel indication, Clinical Rheumatology, 2007, 27, 3, 281

    CrossRef

  61. 61
    David L. Scott, Sophia Steer, The course of established rheumatoid arthritis, Best Practice & Research Clinical Rheumatology, 2007, 21, 5, 943

    CrossRef

  62. 62
    Sergio Durán-Barragán, Graciela S Alarcón, The heart–joints connection: atherosclerosis and inflammation, Expert Review of Clinical Immunology, 2007, 3, 4, 517

    CrossRef

  63. 63
    U. Hofmann, S. Heuer, K. Meder, J. Boehler, V. Lange, T. Quaschning, G. Ertl, A. Bonz, The proinflammatory cytokines TNF-α and IL-1β impair economy of contraction in human myocardium, Cytokine, 2007, 39, 3, 157

    CrossRef

  64. 64
    CARLOS A. ROLDAN, Practice of Clinical Echocardiography, 2007,

    CrossRef

  65. 65
    Víctor M. Martínez-Taboada, ¿Está incrementada la mortalidad cardiovascular en la artritis reumatoide? Posición a favor, Reumatología Clínica, 2006, 2, S45

    CrossRef

  66. 66
    Loreto Carmona, ¿Está incrementada la mortalidad cardiovascular en la artritis reumatoide? Posición en contra, Reumatología Clínica, 2006, 2, S49

    CrossRef

  67. 67
    Miguel A. Gonzalez-Gay, Carlos Gonzalez-Juanatey, Jose A. Miranda-Filloy, Carlos Garcia-Porrua, Javier Llorca, Javier Martin, Cardiovascular disease in rheumatoid arthritis, Biomedicine & Pharmacotherapy, 2006, 60, 10, 673

    CrossRef

  68. 68
    Paulo J. Nicola, Cynthia S. Crowson, Hilal Maradit-Kremers, Karla V. Ballman, Véronique L. Roger, Steven J. Jacobsen, Sherine E. Gabriel, Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis, Arthritis & Rheumatism, 2006, 54, 1
  69. 69
    R. N. Maini, P. C. Taylor, J. Szechinski, K. Pavelka, J. Bröll, G. Balint, P. Emery, F. Raemen, J. Petersen, J. Smolen, D. Thomson, T. Kishimoto, Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate, Arthritis & Rheumatism, 2006, 54, 9
  70. 70
    Carlos Gonzalez-Juanatey, Encarnacion Amigo-Diaz, Jose A. Miranda-Filloy, Ana Testa, Javier Revuelta, Carlos Garcia-Porrua, Javier Martin, Javier Llorca, Miguel A. Gonzalez-Gay, Lack of Echocardiographic and Doppler Abnormalities in Psoriatic Arthritis Patients Without Clinically Evident Cardiovascular Disease or Classic Atherosclerosis Risk Factors, Seminars in Arthritis and Rheumatism, 2006, 35, 5, 333

    CrossRef

  71. 71
    Theodora PM Vliet Vlieland, New models of care for patients with rheumatoid arthritis, Expert Review of Pharmacoeconomics & Outcomes Research, 2006, 6, 2, 159

    CrossRef

  72. 72
    Hilal Maradit Kremers, Sherine E. Gabriel, Rheumatoid arthritis and the heart, Current Heart Failure Reports, 2006, 3, 2, 57

    CrossRef

  73. 73
    W. Seidel, M. Hecker, U. Wagner, H. Häntzschel, Rheumatoide Arthritis und kardiovaskuläre Komplikationen, Zeitschrift für Rheumatologie, 2006, 65, 6, 482

    CrossRef

  74. 74
    Jon T Giles, Wendy Post, Roger S Blumenthal, Joan M Bathon, Therapy Insight: managing cardiovascular risk in patients with rheumatoid arthritis, Nature Clinical Practice Rheumatology, 2006, 2, 6, 320

    CrossRef

  75. 75
    Stacy P Ardoin, John S Sundy, Update on nonsteriodal anti-inflammatory drugs, Current Opinion in Internal Medicine, 2006, 5, 4, 372

    CrossRef

  76. 76
    A. Hidalgo Conde, I. Aguilar Fernández, P. Valdivielso Felices, P. González Santos, Afectación cardíaca en enfermedades sistémicas, Medicine - Programa de Formación Médica Continuada Acreditado, 2005, 9, 44, 2885

    CrossRef

  77. 77
    Cynthia S. Crowson, Paulo J. Nicola, Hilal Maradit Kremers, W. Michael O'Fallon, Terry M. Therneau, Steven J. Jacobsen, Veronique L. Roger, Karla V. Ballman, Sherine E. Gabriel, How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease?, Arthritis & Rheumatism, 2005, 52, 10
  78. 78
    Marcus H Snow, Ted R Mikuls, Rheumatoid arthritis and cardiovascular disease: the role of systemic inflammation and evolving strategies of prevention, Current Opinion in Internal Medicine, 2005, 4, 4, 423

    CrossRef

  79. 79
    Miguel A. Gonzalez-Gay, Carlos Gonzalez-Juanatey, Javier Martin, The Increased Risk of Ventricular Diastolic Dysfunction and Congestive Heart Failure in Patients with Rheumatoid Arthritis Is Independent of the Duration of the Disease, Seminars in Arthritis and Rheumatism, 2005, 35, 2, 132

    CrossRef

  80. 80
    Inmaculada Rincón, Agustín Escalante, Update of tnf-alpha antagonists and cardiovascular disease in rheumatoid arthritis, Current Rheumatology Reports, 2005, 7, 5, 395

    CrossRef